Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/18/2012CN101031339B Lysis/resealing process and device for incorporating an active ingredient in erythrocytes
07/18/2012CN101019967B Process of preparing antiviral medicine composition
07/17/2012US8224438 Method for directed intranasal administration of a composition
07/17/2012US8222456 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
07/17/2012US8222453 Benzamide factor VIIa inhibitors useful as anticoagulants
07/17/2012US8222451 Histone deacetylase inhibitors and methods of use thereof
07/17/2012US8222440 Compounds and methods for the treatment of cancer
07/17/2012US8222424 Arylsulfonamide-based matrix metalloprotease inhibitors
07/17/2012US8222422 Crystal of benzimidazole compound
07/17/2012US8222417 Compound having 11β-HSD1 inhibitory activity
07/17/2012US8222416 Azaindole glucokinase activators
07/17/2012US8222414 Indole compounds as an inhibitor of cellular necrosis
07/17/2012US8222400 Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent
07/17/2012US8222399 Photoreactive polysaccharide, photocrosslinked polysaccharide product and method of making same and medical materials made from the crosslinked polysaccharide
07/17/2012US8222398 Chimeric immunomodulatory compounds and methods of using the same-II
07/17/2012US8222395 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
07/17/2012US8222393 Using U7 polypeptide as diagnostic and therapeutic tool preventing and treating cell proliferative disorders
07/17/2012US8222392 Kit for detection of telomerase reverse transcriptase nucleic acids
07/17/2012US8222381 Derivatives of monosaccharides for drug discovery
07/17/2012US8222300 Methods of treating parkinson's disease using halogenated volatile compounds
07/17/2012US8222299 Administering an allium-related organosulfur compound, results in localized thiosulfinate being non-enzymatically formed in response to localized generation of H2O2 by activated immune system cells of the host
07/17/2012US8222298 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
07/17/2012US8222297 Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents
07/17/2012US8222296 Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders
07/17/2012US8222295 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
07/17/2012US8222294 Combinations of an anti emetic agent and an enkephalinase inhibitor
07/17/2012US8222293 Treating learning deficits with inhibitors of Hmg CoA reductase
07/17/2012US8222292 Liquid cannabinoid formulations
07/17/2012US8222291 Small molecule apoptosis promoters
07/17/2012US8222290 Substituted N-phenyl-bipyrrolidine ureas and therapeutic use thereof
07/17/2012US8222289 Salinosporamides and methods for use thereof
07/17/2012US8222288 Small molecule inhibitors of MDM2 and the uses thereof
07/17/2012US8222287 Substituted anthra[1,2-D]imidazolediones and pharmaceutical utility thereof
07/17/2012US8222286 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
07/17/2012US8222285 1,3-dihydroxy substituted phenylamide glucokinase activators
07/17/2012US8222284 Stable formulations of thiadiazole derivative
07/17/2012US8222283 Method for treating a keratoconjunctival disorder
07/17/2012US8222282 Sulfonate salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
07/17/2012US8222281 Carboxylic acid compound
07/17/2012US8222280 Ether compounds with nitrogen-containing 5-member heterocycle and uses thereof
07/17/2012US8222279 Small molecule insulin mimetics absent quinones
07/17/2012US8222278 Treatment of attention-deficit/hyperactivity disorder
07/17/2012US8222277 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/17/2012US8222276 Amine salt of carbostyril derivative
07/17/2012US8222275 Biarylcarboxyarylamides as vanilloid-1 receptor modulators
07/17/2012US8222274 Pyrrole derivative or salt thereof
07/17/2012US8222273 Polymorphic form of a [1,2,4]triazole[4,3-A] pyridine derivative inflammatory diseases
07/17/2012US8222272 Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
07/17/2012US8222271 Formulations and methods for vascular permeability-related diseases or conditions
07/17/2012US8222269 Tyrosine kinase inhibitors
07/17/2012US8222268 Methods for reducing vein irritation
07/17/2012US8222267 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
07/17/2012US8222266 Azabicyclo [3.1.0] hexyl derivatives as modulators of dopamine D3 receptors
07/17/2012US8222265 Six-membered N-heterocyclic carbene-based catalysts for asymmetric reactions
07/17/2012US8222264 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture
07/17/2012US8222263 Inhibitors of hedgehog pathway
07/17/2012US8222262 Indazolyl derivatives useful as potassium channel modulating agents
07/17/2012US8222261 Chemical compounds
07/17/2012US8222260 Substituted 6-anilinopurine derivatives as inhibitors of cytokinin oxidase/dehydrogenase and preparations containing these derivatives
07/17/2012US8222259 1,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo[4,3-e]-1,2,4-triazolo[4,3-c]pyrimidin-3-one compounds for use as adenosine A2a receptor antagonists
07/17/2012US8222258 Stable pharmaceutical composition of freeze-dried tetrodoxin powder
07/17/2012US8222257 Phosphono-pent-2-en-1-yl nucleosides and analogs
07/17/2012US8222256 Methods of using IGFIR and ABL kinase modulators
07/17/2012US8222255 Antifungal agents
07/17/2012US8222254 1, 2, 4-triazole derivatives as serotonergic modulators
07/17/2012US8222253 Peptide and small molecule agonists of EphA and their uses
07/17/2012US8222251 Pyridopyridazine compounds, compositions and methods of use
07/17/2012US8222249 Isoindoline compounds and methods of their use
07/17/2012US8222248 Organic compounds
07/17/2012US8222247 Modulators of glucocorticoid receptor, AP-1, and/or NF-kappabeta activity and use thereof
07/17/2012US8222246 Substituted isoxazoles
07/17/2012US8222245 Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)
07/17/2012US8222244 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
07/17/2012US8222243 Therapeutic isoxazole compounds
07/17/2012US8222242 Nitric oxide releasing compounds
07/17/2012US8222241 Use of dimiracetam in the treatment of chronic pain
07/17/2012US8222240 Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome
07/17/2012US8222239 quaternary ammonium compounds, conjugated to polymers, used as microbiocides
07/17/2012US8222238 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
07/17/2012US8222237 Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
07/17/2012US8222236 2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs
07/17/2012US8222235 2-methylene-19-nor-(20R)-1α-hydroxy-bishomopregnacalciferol
07/17/2012US8222233 Modifications of solid 3-sn-phosphoglycerides
07/17/2012US8222232 Glucosamine and N-acetylglucosamine compositions and methods of making the same fungal biomass
07/17/2012US8222231 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
07/17/2012US8222230 Pharmaceutical compositions with superior product performance and patient compliance
07/17/2012US8222229 Peritoneal dialysis method
07/17/2012US8222228 Substituted aryl piperidinylalkynyladenosines as A2AR agonists
07/17/2012US8222222 Compositions and methods for inhibiting expression of the PCSK9 gene
07/17/2012US8222219 Glucopyranoside compound
07/17/2012US8222218 Cyclopropanated carbohydrates
07/17/2012US8222212 Prolactin induced increase in neural stem cell numbers
07/17/2012US8222210 Methods of using substance P to promote healing of vascular wounds
07/17/2012US8222200 Organic compounds
07/17/2012US8222002 Human anti-amyloid beta peptide antibody and fragment of said antibody
07/17/2012US8221818 Composition with health and nutrition promoting characteristics, containing interestified lipids and phytosterol, and related methods
07/17/2012US8221802 Antipyrotic formulation for the treatment of epidermal burns
07/17/2012US8221799 Multiple antioxidant optimal health/veterans ultimate complete formulations
07/17/2012US8221796 Copper-based fungicide/bactericide
07/17/2012US8221794 Anti-angiogenic nanoparticle compositions
1 ... 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 ... 7860